Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Through System Optimization and Real-Time Blood Data Monitoring

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChung Shan Medical University

About this trial

This study aims to evaluate the impact of an intelligent care system on radiation therapy patients, focusing on real-time blood data monitoring, optimized patient education, and internal alert systems. The goal is to enhance patient safety, improve treatment adherence, and reduce anxiety by integrating an alert function into the hospital's existing system.

Key interventions include:

Real-time blood monitoring alerts: Healthcare providers will receive automatic notifications of abnormal blood test results to ensure timely intervention.

Optimized patient education materials: Clearer guidance will help patients proactively communicate blood test needs and manage their health during radiation therapy.

Internal reminders: Visual signs and alerts in treatment areas will reinforce patient awareness and engagement.

The study will compare patients receiving these interventions with those under standard care, assessing treatment compliance, anxiety levels, and clinical outcomes over a 12-month period.

Eligibility criteria

Qualifiers

Patients undergoing radiation therapy combined with chemotherapy.

Age ≥ 18 years.

Ability to understand and comply with the study protocol.

Willing to participate in the study and provide informed consent.

Disqualifiers

Patients with severe cognitive impairment or intellectual disability, affecting their ability to understand or follow study procedures.

Patients unwilling to complete study questionnaires.

Any mental health condition (e.g., major depressive disorder, severe anxiety disorder) that could interfere with participation.

Patients with conditions requiring immediate intervention that would make study participation impractical.

Trial design

Treatments tested in this trial

  • Real-Time Blood Data Monitoring System (Device/Software Integration)
  • Enhanced Patient Education Materials (Behavioral/Educational Intervention)
  • Internal Warning Signs and Alerts (Behavioral Intervention)

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators